← All organizations
Hammersmith Medicines Research
For profitWebsite ↗
Also known as: Hammersmith Medicines Cumberland Avenue London NW10 7EW UK | Hammersmith Medicines Research | Hammersmith Medicines Research Cumberland Avenue London NW10 EW UK | Hammersmith Medicines Research Cumberland Avenue Park Royal London NW10 7EW, England Telephone: +44 020 8961 4130 Fax: +44 020 8961 8665 | Hammersmith Medicines Research (HMR) | Hammersmith Medicines Research Limited | Hammersmith Medicines Reserach | HMR | Trio Medicines Limited | Trio Medicines Ltd.
Highest phase reached
Phase 2
First clinical trial
May 1, 1996Last known activity
Dec 25, 2025
Timeline
1990s
- Jun 1, 1993
Hammersmith Medicines Research— Founded
Drugs by trial phase (46 distinct, 53 trials)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (41 own, 0 via acquisition)
Indications
Studied for
- alpha 1-Antitrypsin Deficiency
- Aspergillosis
- Asthma
- Atrophy
- Bacterial Infections
- Barrett Esophagus
- Carcinoid Tumor
- Communicable Diseases
- Dyslipidemias
- Dyspepsia
- Esophagitis
- Esophagitis, Peptic
- Filariasis
- Gastrinoma
- Gastritis
- Gastritis, Atrophic
- Gastroesophageal Reflux
- Hyperplasia
- Hypertension, Pulmonary
- Immune System Diseases
- Infections
- Influenza, Human
- Lung Diseases
- Malaria
- Malaria, Falciparum
- Multiple Sclerosis
- Osteoarthritis
- Parkinson Disease
- Pulmonary Disease, Chronic Obstructive
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Syndrome
- Zollinger-Ellison Syndrome
Recent trials (50)
- NCT07251712OfficialPhase 1Dec 25, 2025
- NCT06092788Overall official - principal investigatorPhase 1Nov 30, 2023
- NCT06092788CollaboratorPhase 1Nov 30, 2023
- NCT05725005CollaboratorPhase 1Feb 6, 2023
- NCT05725005Overall official - principal investigatorPhase 1Feb 6, 2023
- NCT04919863CollaboratorPhase 1May 24, 2021
- NCT04919863Overall official - principal investigatorPhase 1May 24, 2021
- NCT04673383Overall official - principal investigatorPhase 1/Phase 2Feb 4, 2021
- NCT04443192CollaboratorPhase 1Aug 3, 2020
- NCT04443192Overall official - principal investigatorPhase 1Aug 3, 2020
- NCT04449939Overall official - principal investigatorPhase 1Jul 7, 2020
- NCT04171739CollaboratorPhase 1Nov 18, 2019
- NCT04171739Overall official - principal investigatorPhase 1Nov 18, 2019
- NCT03774173Overall official - principal investigatorPhase 1Dec 8, 2018
- NCT03774173CollaboratorPhase 1Dec 8, 2018
Details
- Founded
- London, GB Jun 1, 1993
- Last known activity
- Dec 25, 2025